Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study
The combined use of SGLT2i and GLP-1RA was associated with a significantly decreased risk of MACE primarily driven by the lowering risks of all-cause mortality and nonfatal stroke in T2D patients with ACS, compared with SGLT2i use alone.
Authors
- Zeyuan Fan (ORCID: https://orcid.org/0000-0001-8923-0141)
- Bing Xiao (ORCID: https://orcid.org/0000-0001-9526-4575)
- Tao Liu (ORCID: https://orcid.org/0000-0001-5347-5892)
- Yuntao Li (ORCID: https://orcid.org/0000-0001-8788-7537)
- He Chang
Institutions
- Aviation General Hospital (CN)
Publication Details
- Journal
- International Journal of Cardiology
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1016/j.ijcard.2025.133229
- Citations
- 16
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 20.72